Trafalgar International GCAN
OTC GCAN
$0.35 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Trafalgar International (GCAN) Amortizatization of Intangibles (2017 - 2022)

Trafalgar International (GCAN) posted Amortizatization of Intangibles of $98342.0 for Q1 2022, up 39.81% on a QoQ basis from $70339.0 in Q4 2021, and up 714.22% year-over-year from $12078.0 in Q1 2021.

Analysis

Trafalgar International (GCAN) Amortizatization of Intangibles (2017 - 2022) Analysis & Trends

Trafalgar International has reported Amortizatization of Intangibles for 6 years, with the latest figure at $98342.0 in Q1 2022.

  • On a quarterly basis, Amortizatization of Intangibles rose 714.22% year-over-year to $98342.0 in Q1 2022; TTM through Dec 2022 was $98342.0, a 63.42% decrease from a year earlier, with the FY2022 full-year figure at $98342.0, down 63.42% from the prior year.
  • Amortizatization of Intangibles was $98342.0 for Q1 2022 at Trafalgar International, up from $70339.0 in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $394800.0 in Q2 2020, with the low at $4986.0 in Q4 2018.
  • Average Amortizatization of Intangibles over 5 years is $112640.6, with a median of $68691.0 recorded in 2021.
  • The sharpest annual moves came in 2019 and 2021: Amortizatization of Intangibles surged 5764.52% in 2019, then sank 95.93% in 2021.
  • Over 5 years, Amortizatization of Intangibles stood at $4986.0 in 2018, then soared by 5764.52% to $292405.0 in 2019, then tumbled by 50.26% to $145450.0 in 2020, then sank by 51.64% to $70339.0 in 2021, then soared by 39.81% to $98342.0 in 2022.
  • The last three Amortizatization of Intangibles figures came in at $98342.0 (Q1 2022), $70339.0 (Q4 2021), and $117746.0 (Q3 2021), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn -
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn -
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 984.00 Mn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn -
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn -
7 Revolution Medicines 43.79 Bn 43.79 Bn - 4.33 Mn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn -
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn -
10 Trafalgar International 217,335.05 217,335.05 - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 98,342.00
Dec 31, 2021 70,339.00
Sep 30, 2021 117,746.00
Jun 30, 2021 68,691.00
Mar 31, 2021 12,078.00
Dec 31, 2020 145,450.00
Sep 30, 2020 178,280.00
Jun 30, 2020 394,800.00
Mar 31, 2020 297,073.00
Dec 31, 2019 292,405.00
Sep 30, 2019 68,054.00
Jun 30, 2019 67,314.00
Mar 31, 2019 35,717.00
Dec 31, 2018 4,986.00
Sep 30, 2018 17,866.00
Jun 30, 2018 23,769.00
Mar 31, 2018 21,980.00
Dec 31, 2017 17,329.00
Sep 30, 2017 14,445.00
Jun 30, 2017 5,425.00